Lumedica Vision
PrivateLast Round
Debt
Dec 28, 2022
Total Funding Raised
$1.78M
Company Overview
Lumedica Vision operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Debt round in December 2022.
Lumedica Vision is a medical technology company that develops affordable, portable optical coherence tomography (OCT) imaging systems for ophthalmic and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumedica Vision Comparables
Compare Lumedica Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Philophos | 87% | |
| Theia Imaging | 86% | |
| JuneBrain | 84% |
For institutional investors. Book with your work email.
Lumedica Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 28, 2022 | ||||
| Early Funding | Jun 4, 2021 | ||||
| Grant | Jul 9, 2019 | ||||
| Accelerator | Jun 27, 2019 | ||||
| Debt | Mar 15, 2019 | ||||
Seed | Mar 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lumedica Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Eye Institute (NIH) | Grant |
| NIH RADx | Grant |
| Luminate Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2022
$151K debt round raised.
- Jun 4, 2021
$200K raised in early funding.
For institutional investors. Book with your work email.
Lumedica Vision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lumedica Vision's valuation, stock price, and market status.
Is Lumedica Vision a public or private company?
Lumedica Vision is a private company.
What is the current stock price of Lumedica Vision?
Lumedica Vision is a private company, so its shares have no public market price. Caplight tracks Lumedica Vision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lumedica Vision worth (valuation)?
Valuation information for Lumedica Vision is not publicly available.
Can I buy Lumedica Vision stock?
Lumedica Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lumedica Vision's last funding round?
Lumedica Vision's most recent funding round was Debt on December 28, 2022.
Who are the main investors in Lumedica Vision?
Key investors in Lumedica Vision include National Eye Institute (NIH), NIH RADx, Luminate Accelerator.
Will Lumedica Vision IPO soon?
No public IPO plans have been announced for Lumedica Vision.
How can I track Lumedica Vision secondary market activity?
Caplight tracks bids, offers, and trades in Lumedica Vision's shares on secondary markets.